E3D-C Interbody System
Evolution Spine · Decision date Jul 22, 2026
What did the FDA decide?
FDA records K262094 as a 510(k) premarket notification, with a decision dated Jul 22, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Jul 22, 2026
Regulatory record facts
- Identifier
- K262094
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Evolution Spine
- Product code
- OVE
- Decision code
- SESE
- Decision date
- Jul 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Intervertebral Fusion Device With Integrated Fixation, Cervical.
- Applicant
- Evolution Spine
- Product code
- OVE
- FDA device class
- 2
FDA decision timeline
K262094 received
Application receipt date recorded by FDA.
K262094 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OVE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ZSFab, Inc. | 510(k) clearance | Oct 2, 2026 | FDA | |
NeckTune SA Cervical CageK262726 | Medyssey Co., Ltd. | 510(k) clearance | Sep 29, 2026 | FDA |
SABER-C SystemK263049 | Elevation Spine | 510(k) clearance | Sep 23, 2026 | FDA |
| Osseus Fusions Systems, LLC | 510(k) clearance | Aug 21, 2026 | FDA | |
| ZSFab, Inc. | 510(k) clearance | Jul 31, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Evolution Spine
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Dallas, TX
Sources and methodology
- Original FDA record: K262094
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


